Lv1
20 积分 2025-07-10 加入
Multicenter Interspecialty Consensus on Experimental Oncology Drug–Related Ocular Adverse Event Reporting
4个月前
已完结
Bench-to-Bedside Perspectives on Ocular Toxicity of Antibody-Drug Conjugates: Toxicology, Clinical Management and Molecule Optimization
4个月前
已完结
OA-65 Overall Survival (OS) With Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care (SoC) in Lenalidomide (Len)-Refractory Multiple Myeloma (MM): Phase 3 CARTITUDE-4 Study Update
6个月前
已关闭
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
7个月前
已完结
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
11个月前
已完结
老年多发性骨髓瘤全程管理专家共识
1年前
已完结
皖公网安备34019202002308
